Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder

There are currently five programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors approved for the treatment of locally advanced or metastatic urothelial carcinoma (UC) of the bladder. For platinum-ineligible patients, testing of tumor specimens for PD-L1 expression is required. Howeve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Tosev, Georgi, Wahafu, Wasilijiang, Reimold, Philipp, Damgov, Ivan, Schwab, Constantin, Aksoy, Cem, Kaczorowski, Adam, Stenzinger, Albrecht, Nyarangi-Dix, Joanne, Hohenfellner, Markus, Duensing, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8270894/
https://ncbi.nlm.nih.gov/pubmed/34244564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-93754-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados